Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: Italy Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20111
20171
20181
20191
20203
20213
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed5
Active, not recruiting2
Suspended1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
AbbVie (prior sponsor, Abbott)1
Adherex Technologies, Inc.1
Astellas Pharma Inc1
BicycleTx Limited1
Bristol-Myers Squibb1
Catholic University of the Sacred Heart1
Clavis Pharma1
Clovis Oncology, Inc.1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms18
Endometrial Neoplasms10
Breast Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Neoplasms5
Uterine Cervical Neoplasms5
Colorectal Neoplasms4
Neoplasm Metastasis4
Triple Negative Breast Neoplasms4
Fallopian Tube Neoplasms3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.